
Current Trends in Breast Cancer Pathology, Screening, Diagnosis and Treatments
- 1st Edition - January 1, 2026
- Editor: Firdos Alam Khan
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 3 3 3 4 7 - 7
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 3 3 3 4 8 - 4
The book “Cutting-edge Computational Intelligence in Healthcare with Convolution and Kronecker Convolution-based Approaches” discusses how advanced deep learning techniques… Read more

The book begins by explaining foundational concepts of deep learning and Convolutional Neural Networks (CNNs) to show how they extract meaningful features from medical images for tasks such as diagnosis and segmentation. It then explores Kronecker convolutions, highlighting their ability to better capture spatial hierarchies, use parameters more efficiently, and adapt to unique medical image characteristics. Subsequent sections cover applications like tumor detection, organ segmentation, and disease classification and examine real-world implementations of AI in diagnostic imaging, precision medicine, and continuous health monitoring through wearable devices. The final section addresses challenges, emerging trends, and future directions, emphasising how these techniques could shape advanced healthcare. Throughout the book, the authors bridge medicine, computer science, and machine learning to address complex problems in medical imaging and healthcare.
• Investigates opportunities and challenges of deep learning, including convolutional neural networks (CNNs) and their applications in medical image processing
• Includes comprehensive examination and elucidation of Kronecker convolutional procedures and their significance in medical image processing
• Explores specific medical imaging tasks where Kronecker convolutions prove beneficial
• Provides detailed examples demonstrating how convolutions may be employed to improve healthcare, offering insights into how deep learning is currently being used in clinical settings
1. Breast cancer: Definition, history, symptoms, causes, worldwide scenario of breast cancer, breast cancer statistics globally
2. Breast cancer pathology, microscopic analysis, stages and classifications
3. Breast cancer molecular pathology, signalling pathways, genetic and epigenetic role
4. Breast cancer diagnosis, tools and techniques
5. Breast cancer treatment using surgical intervention, methods, advantages and disadvantages of surgical intervention
6. Breast cancer treatment using chemotherapy methods, advantages and disadvantages of chemotherapy
7. Breast cancer treatment using radiation therapy, advantages and disadvantages of radiation therapy
8. Breast cancer treatment using immunotherapy, advantages and disadvantages of immunotherapy
9. Problems and side effects with currently used breast cancer treatments
10. Impact of breast cancer on patient’s quality of life
11. Prevention Strategies and Public Health: Breast cancer prevention, including lifestyle changes, risk assessment, and early intervention
12. Future trends and innovation in breast cancer diagnosis and treatments
- Edition: 1
- Published: January 1, 2026
- Language: English
FK
Firdos Alam Khan
Prof. Firdos Alam Khan is a Chairman of the Department of Stem Cell Biology, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia. Prof. Khan has done his Ph.D. degree in Zoology with a Neuroscience specialization from Nagpur University, India. Over the past years, he has been involved in teaching various courses to undergraduate and postgraduate students. Prof. Khan has been granted 8 US patents and published 5 US patents. Professor Khan has authored and edited several books. Prof. Khan has been a recognized reviewer in several scientific journals. Prof. Khan is listed among the top 2% scientists of the world by Stanford University Top Scientists Ranking 2022. Prof. Khan has published 115 research papers in peer-reviewed journals. Prof. Khan is currently studying the therapeutic impact of different biomolecules, biomaterials, and nanomaterials on breast, colorectal and cervical cancer cells, non-cancerous cells and stem cells.